Log in
Enquire now
Enliven Therapeutics

Enliven Therapeutics

Enliven Therapeutics is a cancer Treatments.

OverviewStructured DataIssuesContributors

Contents

enliventherapeutics.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Pharmaceutical industry
Pharmaceutical industry
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Technology
Technology
Biology
Biology
Oncology
Oncology
Drug discovery
Drug discovery
...
Location
Boulder, Colorado
Boulder, Colorado
0
Pitchbook URL
pitchbook.com/profiles...454790-26
Email Address
info@enliventherapeutics.com0
hr@enliventherapeutics.com0
Phone Number
+172064785190
Full Address
6200 Lookout Road Boulder, CO 80301, United States0
Investors
Boxer Capital
Boxer Capital
Surveyor Capital
Surveyor Capital
Cormorant Asset Management
Cormorant Asset Management
Janus Henderson Investors
Janus Henderson Investors
Logos Capital
Logos Capital
Total Funding Amount (USD)
85,000,000
Latest Funding Round Date
January 19, 2022
Competitors
Code Biotherapeutics
Code Biotherapeutics
Meenta
Meenta
Latest Funding Type
Series B
Series B
Country
United States
United States

Other attributes

Latest Funding Round Amount (USD)
85,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Enliven Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.